Identifying High-Risk Patients With ASCVD and Reducing the Burden of Elevated LDL-C
Industry Podcast Sponsored by Novartis Pharmaceuticals Corporation, US Medical Affairs; Not for CME/CE Credit
This podcast discusses the identification and management of patients with atherosclerotic cardiovascular disease (ASCVD) and highlights opportunities to reduce the overall burden of elevated low-density lipoprotein cholesterol (LDL-C).
This content is developed exclusively by or on behalf of the industry sponsor through a third party and is not reviewed by Pri-Med. The content and opinions expressed are those of the sponsor or presenters and may not reflect the views of Pri-Med.
166451 11/21
Associate Clinical Professor of Medicine
Geffen School of Medicine-UCLA
Cedars-Sinai Medical Center
Co-editor, Reviews in Cardiovascular Medicine
Co-director, Cardiovascular Imaging
Westside Medical Imaging/
Westside Medical Associates of Los Angeles
